awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35204279-A62CA17E-0F59-40F9-94C8-13EB5CD11CDD
Q35204279-A62CA17E-0F59-40F9-94C8-13EB5CD11CDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35204279-A62CA17E-0F59-40F9-94C8-13EB5CD11CDD
Antiretroviral therapy: when to start
P2860
Q35204279-A62CA17E-0F59-40F9-94C8-13EB5CD11CDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35204279-A62CA17E-0F59-40F9-94C8-13EB5CD11CDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d5752a9a0e2f68c4d96ff4561c3c62a92d9cccd
P2860
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks